Clinical Trial Update: Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating zimberelimab in combination with metformin for recurrent ovarian clear cell carcinoma is underway (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Clear Cell Carcinoma

Drugs mentioned

• Zimberelimab (zimberelimab)
• metformin (metformin)

Snippet

Sponsor: Fudan University | Conditions: Ovarian Clear Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN